Physician profile
Andrew Lambour
NPI 1285077909
$4,897.42
in general payments reported to CMS, 2019-2025
11 companies · $42.81 in 2025
The $42.81 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,551 · 2020: $2,852 · 2021: $80.80 · 2022: $21.81 · 2023: $298 · 2024: $51.51 · 2025: $42.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,520.13 | 2019-2023 | Da Vinci Surgical System |
| Paladin Technology Solutions | $62.18 | 2023 | |
| Tela Bio, INC. | $56.45 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $52.47 | 2020-2021 | |
| Smith+Nephew, INC. | $50.03 | 2023-2025 | Stravix, Stravix Pl, Grafix Pl |
| Bioventus LLC | $49.53 | 2023 | |
| Shockwave Medical, INC | $24.62 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $21.81 | 2022 | |
| Davol INC. | $21.77 | 2023 | Phasix Mesh |
| Mozarc Medical US LLC | $21.10 | 2024 | Argyle |
| Innocoll Pharmaceuticals Limited | $17.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lambour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.